[PDF][PDF] Exploring the efficacy of naturally occurring CC and COC type biflavonoids towards the inhibition of MDM2-p53 interactions

S Karmakar, S Majumdar, B Singh, A Pramanik… - 2024 - researchgate.net
Abstract P53-MDM2 protein-protein interaction (PPI) is one of the most well-established
studied which is involved in human cancer. Most importantly, cell cycle and apoptosis are …

Screening of medicinal plant phytochemicals as natural antagonists of p53–MDM2 interaction to reactivate p53 functioning

M Riaz, UA Ashfaq, M Qasim, E Yasmeen… - Anti-cancer …, 2017 - journals.lww.com
In most types of cancer, overexpression of murine double minute 2 (MDM2) often leads to
inactivation of p53. The crystal structure of MDM2, with a 109-residue amino-terminal …

Discovery of novel 2, 5-diphenyl furan scaffold-based derivative as potential p53-MDM2 interaction inhibitor, an important target for cancer therapy

S Karmakar, S Majumdar, B Panda, B Singh… - Available at SSRN … - papers.ssrn.com
Abstract P53-MDM2 protein-protein interaction (PPI) is one of the most crucial and
intensively studied PPIs involved in human cancer. Importantly, cell cycle and apoptosis are …

The molecular docking of flavonoids isolated from Daucus carota as a dual inhibitor of MDM2 and MDMX

I Muhammad, N Rahman, GE Nayab… - Recent Patents on …, 2020 - ingentaconnect.com
Background: Cancer is characterized by overexpression of p53 associated proteins, which
down-regulate P53 signaling pathway. In cancer therapy, p53 activity can be restored by …

[PDF][PDF] Targeting p53-MDM2 interaction by natural plant products: A novel approach for future cancer therapy

S Rosaweg, NA Willemstad Curacao - Int. J. Life. Sci. Scienti. Res, 2017 - academia.edu
P53 is a tumor suppressor gene with a well established role in causation of different human
cancers. The p53-MDM2 interactions have become the cornerstone of intensive cancer …

Insight on Heterocycles as p53‐MDM2 Protein‐Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation

NJ Basha, RM Mohan - ChemistrySelect, 2024 - Wiley Online Library
Transcription factor p53, also known as tumor suppressor protein. Encoded by the TP53
gene, the guardian of genome p53 regulates many gene pathways. Nevertheless, the …

p53-Mdm2 interaction inhibitors as novel nongenotoxic anticancer agents

SK Nayak, GL Khatik, R Narang… - Current cancer drug …, 2018 - ingentaconnect.com
Background: Cancer is a major global health problem with high mortality rate. Most of the
clinically used anticancer agents induce apoptosis through genotoxic stress at various …

Promising disruptors of p53-MDM2 dimerization from some medicinal plant phytochemicals: a molecular modeling study

AQK Oyedele, TI Adelusi, AT Ogunlana… - Journal of …, 2023 - Taylor & Francis
Cancer is a major global health issue that has a high mortality rate. p53, which functions as
a tumor suppressor, is critical in preventing tumor development by regulating the cell cycle …

Molecular docking and molecular dynamics studies reveal the anticancer potential of medicinal-plant-derived lignans as MDM2-P53 interaction inhibitors

TH Shoaib, N Abdelmoniem, RM Mukhtar, AT Alqhtani… - Molecules, 2023 - mdpi.com
The interaction between the tumor suppressor protein p53 and its negative regulator, the
MDM2 oncogenic protein, has gained significant attention in cancer drug discovery. In this …

Hinokiflavone, as a MDM2 inhibitor, activates p53 signaling pathway to induce apoptosis in human colon cancer HCT116 cells

S Zhang, Y Wang, Y Sun, G Zhao, J Wang, L Liu… - Biochemical and …, 2022 - Elsevier
Hinokiflavone (HF), a natural biflavonoid that possesses various biological activities, has
reported that HF could be a pre-mRNA splicing modulator, whereas its underlying …